CrystalGenomics buys Hwail for 46.8 billion won

Published: 2013-08-19 06:57:00
Updated: 2013-08-19 06:57:00
Korea’s emerging biotech company CrystalGenomics Inc. said Tuesday it reached a deal to buy Hwail Pharm, a pharmaceutical raw material manufacturer, for 46.8 billion won.

The stock purchase agreement calls for the takeover of a 21.66 percent stake in Hwail currently owned by Hwail’s two larges...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.